Gastroenterology Billing — Endoscopy Bundling, Colonoscopy Coding & Every High-Value Procedure Paid
Gastroenterology billing is defined by one rule above all others — endoscopy bundling. The difference between a correctly unbundled GI procedure claim and an incorrectly bundled one is hundreds of dollars per case. Add colonoscopy screening vs diagnostic distinction, capsule endoscopy billing, infusion therapy coding, and prior authorization on nearly every high-value GI procedure — and you have a specialty where precise billing knowledge pays for itself many times over. Netix handles every layer so your gastroenterologists scope patients while we make sure every procedure gets paid in full.
Endoscopy bundling rules applied correctly on every claim
Colonoscopy screening vs diagnostic distinction handled
Prior auth management for all high-value GI procedures
THE PROBLEM
Why Gastroenterology Practices Lose Thousands Per Procedure Day
GI billing errors are high-value errors — because GI procedures are high-value. A bundling mistake on a colonoscopy with polypectomy, a wrong screening vs diagnostic distinction, or a missed prior authorization on a capsule endoscopy does not cost $15. It costs hundreds per case — multiplied across every procedure day. Here is where the losses happen most consistently
Endoscopy bundling rules are the most complex in all of outpatient procedural billing
The endoscopy bundling concept in gastroenterology works differently from other specialties — when multiple endoscopic procedures are performed during the same session, the less complex procedure is not billed separately at full value. Instead, only the difference in RVUs between the lesser procedure and the base endoscopy is separately payable. Getting this wrong in either direction — bundling when separate billing applies, or unbundling when it does not — creates either audit exposure or lost revenue on every multi-procedure case.
Colonoscopy screening vs diagnostic distinction is the highest-denial-risk area in GI billing
Medicare and most commercial payers cover screening colonoscopies (no symptoms, routine prevention) at a different cost-sharing level than diagnostic colonoscopies (symptoms, follow-up of abnormal finding). The CPT code distinction (G0121 vs 45378 for Medicare) and the diagnosis code applied determine which category the claim falls into — and which cost-sharing applies to the patient. Getting this wrong means either a patient being charged incorrectly or a claim denying for coverage category mismatch.
Polyp removal during a screening colonoscopy changes the coding — and most practices get it wrong
When a screening colonoscopy finds and removes a polyp, the procedure converts from a screening to a procedure that included a therapeutic intervention — but for Medicare patients, the screening intent is preserved and cost-sharing rules still apply. The CPT code changes (from G0121 to 45385 for colonoscopy with polypectomy) but the screening diagnosis code is maintained. Most GI practices either miss the code conversion or apply it incorrectly, causing both billing errors and patient cost-sharing disputes.
Upper endoscopy bundling with biopsy is wrong in most practices
EGD with biopsy (43239) is a single CPT code — it is not an EGD (43235) billed separately plus a biopsy add-on. Billing 43235 + a separate biopsy code is unbundling and an audit trigger. The biopsy is included in 43239. Similarly, EGD with dilation (43249) includes the diagnostic component — billing 43235 separately alongside 43249 is incorrect.
Capsule endoscopy billing requires prior authorization that most practices do not obtain
Capsule endoscopy (91110 small bowel, 91111 esophageal) requires prior authorization from most commercial payers — and the auth documentation must establish that prior endoscopy was non-diagnostic or contraindicated. Missing auth on a capsule endoscopy means a denial on a procedure with significant cost.
Infusion therapy billing in GI is almost universally underbilled
Biologics administered in GI offices for Crohn's disease, ulcerative colitis, and other inflammatory conditions — infliximab, vedolizumab, ustekinumab — require infusion billing (96365–96368) plus drug supply billing (J-codes) plus prior authorization. Most GI practices either miss infusion administration billing, miss drug supply billing, or miss one of the two components consistently.
OUR GASTROENTEROLOGY BILLING SERVICES
What Netix Handles for Gastroenterology Practices
Colonoscopy Billing
Correct CPT code selection across the colonoscopy family — screening (G0121/G0105 Medicare, 45378 commercial), diagnostic (45378), with polypectomy (45385), with biopsy (45380), with ablation (45388), with control of bleeding (45382) — with screening vs diagnostic distinction handled correctly on every case and polyp removal code conversion applied automatically.
Upper Endoscopy Billing
EGD diagnostic (43235), with biopsy (43239), with dilation (43249), with band ligation (43244), with injection (43236), with ablation (43229) — correct single-code selection for the procedure performed, not unbundled component billing that creates audit exposure.
Endoscopy Bundling Rules
Correct application of endoscopy bundling when multiple procedures are performed in the same session — billing the difference in work between the lesser and base procedure where applicable, and identifying where distinct anatomic sites or circumstances justify separate billing.
Flexible Sigmoidoscopy Billing
Flexible sigmoidoscopy (45330–45345) correctly distinguished from colonoscopy — with correct procedure code selection when the scope does not reach the cecum and the procedure is documented as sigmoidoscopy, not colonoscopy.
Capsule Endoscopy Billing
Small bowel capsule endoscopy (91110) and esophageal capsule endoscopy (91111) — with Prior authorization obtained before the procedure, clinical documentation of prior endoscopy failure or contraindication prepared for auth submission, and reading/interpretation billing separated correctly.
ERCP Billing
Endoscopic retrograde cholangiopancreatography (43260–43278) — correct code selection by procedure performed (diagnostic, with stone removal, with stent placement, with sphincterotomy), prior auth management, and hospital vs ambulatory surgery center billing distinction.
Infusion Therapy Billing
Biologic infusion administration (96365 first hour, 96366 each additional hour) plus drug supply J-codes (J1745 infliximab, J0179 vedolizumab, J0248 ustekinumab) — complete two-component billing for every infusion encounter, with prior auth on every biologic and step therapy documentation prepared for auth submission.
Liver Biopsy & Procedure Billing
Percutaneous liver biopsy (47000), EUS-guided procedures, anorectal manometry (91122), esophageal manometry (91010–91013), Bravo pH capsule placement (91035) — correctly billed as separate billable services with appropriate prior auth.
Hemorrhoid Treatment Billing
Rubber band ligation (46221), sclerotherapy (46500), hemorrhoidectomy (46250–46262) — correct procedure code selection by treatment method and extent, with distinction between office-based and surgical facility billing.
Anorectal Procedure Billing
Anoscopy (46600–46615), colonoscopy through stoma (44388–44408), rectal biopsy (45100), anal fistula treatment — correct CPT selection by approach and extent, with prior auth where required.
E&M Level Optimization
MDM-based E&M review for gastroenterology — complex IBD management, hepatology follow-up, and GI cancer surveillance visits frequently support higher E&M levels than practices bill as a default.
Prior Authorization Management
Capsule endoscopy, ERCP, biologic infusions, EUS with FNA, and high-value diagnostic procedures — auth obtained before scheduling, clinical documentation prepared for medical necessity review, and step therapy failure documentation for biologic auth submissions.
Denial Management — GI Specific
Endoscopy bundling disputes, screening vs diagnostic colonoscopy denials, infusion drug supply denials, capsule endoscopy medical necessity denials, and prior auth denials on high-value GI procedures — appealed with GI-specific clinical documentation and procedure reports.
COLONOSCOPY BILLING EXPLAINED
Colonoscopy Billing — Screening vs Diagnostic vs Therapeutic
Colonoscopy billing is the most nuanced coding decision in gastroenterology — and the most financially consequential when it is wrong.
Screening colonoscopy — no symptoms, routine prevention
Medicare: G0121 (average risk) or G0105 (high risk) Commercial: 45378 with a screening diagnosis code (Z12.11) Coverage: generally at reduced or zero patient cost-sharing Frequency: every 10 years for average risk, more frequently for high risk
Diagnostic colonoscopy — symptoms or follow-up of abnormal finding
Medicare and commercial: 45378 Diagnosis: symptoms (rectal bleeding, change in bowel habits, abdominal pain) or follow-up of prior polyp Coverage: subject to standard deductible and cost-sharing — patient pays more
Incomplete colonoscopy
When the colonoscope does not reach the cecum and the procedure is incomplete — the colonoscopy code is billed with modifier 53 (discontinued procedure) and a lower payment applies. Billing the full colonoscopy code for an incomplete procedure is overbilling.
Why this matters financially
A patient who expected a screening colonoscopy (zero cost-sharing) receiving a bill for a diagnostic colonoscopy cost-sharing amount after a polyp was found is the most common patient billing complaint in gastroenterology. Getting the coding right protects both the claim and the patient relationship.
The polyp removal conversion — where most practices get it wrong
When a screening colonoscopy finds and removes a polyp:
The CPT code changes: G0121 → 45385 (with snare polypectomy) or 45380 (with biopsy)
For Medicare: the screening intent is preserved — diagnosis code Z12.11 is maintained alongside the polyp finding code
For commercial payers: rules vary — some maintain screening cost-sharing, others convert to diagnostic cost-sharing
What we do
Screening vs diagnostic determination on every colonoscopy case before billing, automatic polyp removal code conversion with correct diagnosis code maintenance, and patient cost-sharing calculation that matches what the patient was told to expect.
ENDOSCOPY BUNDLING EXPLAINED
Endoscopy Bundling Rules — Why Two Procedures Do Not Always Mean Two Full Payments
Endoscopy bundling in gastroenterology is unique — it does not work like standard multiple procedure reduction rules.
The concept:
When multiple endoscopic procedures are performed during the same session via the same scope, the lesser procedure is not billed at its full standalone value. Instead, CMS pays the difference in work RVUs between the lesser procedure and the base endoscopy (the diagnostic version of the same scope).
Example:
Colonoscopy with polypectomy (45385) performed during the same session as colonoscopy with biopsy (45380):
- 45385 is the higher-value procedure — billed at full value
- 45380 would be the lesser — but instead of billing 45380 at 50% (standard multiple procedure rule), only the difference between 45380 and 45378 (base diagnostic colonoscopy) is separately payable
- This is the endoscopy bundling concept — and most GI billing services apply standard multiple procedure reduction instead
Where separate billing does apply:
Different anatomic sites within the same session (upper and lower endoscopy), or distinctly different procedures through different scopes, may justify separate billing — but the same-scope, same-session rule applies strictly within each scope family.
What we do:
Procedure-by-procedure bundling analysis on every multi-procedure GI case — correct application of endoscopy bundling where it applies, identification of separately billable procedures where distinct site rules justify it, and pre-submission audit to catch bundling errors before payers use them as denial or audit triggers.
GI CPT CODES WE KNOW COLD
Gastroenterology CPT Codes — Handled by Specialists
| CPT Code | Service | Common Issue |
|---|---|---|
| G0121 | Screening colonoscopy average risk Medicare | Converted to diagnostic incorrectly |
| G0105 | Screening colonoscopy high risk Medicare | Average vs high risk confusion |
| 45378 | Colonoscopy diagnostic | Screening diagnosis code on diagnostic visit |
| 45380 | Colonoscopy with biopsy | Bundling with polypectomy code |
| 45385 | Colonoscopy with polypectomy | Screening conversion missed |
| 45388 | Colonoscopy with ablation | Prior auth missed |
| 45382 | Colonoscopy bleeding control | Documentation of bleeding missed |
| 43235 | EGD diagnostic | Unbundled with biopsy code — audit risk |
| 43239 | EGD with biopsy | Biopsy separately billed — overbilling |
| 43249 | EGD with dilation | Diagnostic component incorrectly added |
| 43244 | EGD with band ligation | Prior auth missed |
| 43260 | ERCP diagnostic | High-value — auth required |
| 43264 | ERCP with stone removal | Add-on procedures missed |
| 43266 | ERCP with stent placement | Stent supply billing missed |
| 91110 | Capsule endoscopy small bowel | Prior auth universally required |
| 91111 | Capsule endoscopy esophageal | Reading component billed separately |
| 96365 | IV infusion first hour | Drug supply J-code missed |
| 96366 | IV infusion additional hour | Add-on hours underbilled |
| J1745 | Infliximab supply | Prior auth and step therapy required |
| 47000 | Liver biopsy percutaneous | Separately billable from E&M |
| 46221 | Hemorrhoid band ligation | Office vs facility billing distinction |
| 91010 | Esophageal manometry | Prior auth on most commercial payers |
| 91122 | Anorectal manometry | Separately billable — often missed |
| 99202–99215 | Office E&M visits | Systematic undercoding on complex IBD |
INFUSION THERAPY BILLING
Biologic Infusion Billing in GI — Two Components, Both Required
Biologic infusion therapy for Crohn’s disease and ulcerative colitis is one of the highest-value services in gastroenterology — and one of the most consistently underbilled.
The two components:
Every biologic infusion has two separately billable parts — the administration (what the nurse does) and the drug supply (what was infused).
Administration billing:
96365: IV infusion, therapeutic, first 15 minutes through first hour
96366: Each additional hour (add-on)
96367: Additional sequential infusion (different drug, same session)
Drug supply billing — J-codes:
J1745: Infliximab (Remicade) — billed per unit (10mg)
J0179: Vedolizumab (Entyvio) — billed per unit
J0248: Ustekinumab (Stelara) — billed per unit
J0717: Certolizumab pegol (Cimzia) — billed per unit
What most GI practices get wrong:
Missing J-code billing entirely — submitting only the administration codes without the drug supply. Missing additional hour add-ons when infusions run beyond the first hour. Not obtaining prior authorization before the infusion — biologic drugs require auth from virtually every commercial payer, with step therapy failure documentation required.
What we handle:
Two-component billing on every infusion encounter, per-unit J-code calculation based on dose administered, prior auth with step therapy documentation, and drug supply denial management when payers dispute dosage or coverage.
Who We Serve
Gastroenterology Providers We Work With
General GI practices
Full endoscopy billing, colonoscopy coding, and E&M optimization
Interventional GI
ERCP, EUS, and complex therapeutic endoscopy billing
IBD specialty practices
Biologic infusion billing, step therapy auth management, and chronic disease E&M optimization
Hepatology practices
Liver biopsy billing, hepatology E&M coding, and transplant-related billing
Colorectal surgery practices
Surgical procedure billing alongside endoscopy, with global period management
Ambulatory surgery centers
ASC-specific GI billing rules, facility fee billing, and implant/supply billing
Multi-physician GI groups
Per-physician and per-procedure performance reporting with consistent coding
RESULTS WE BUILD TOWARD
What Gastroenterology Billing Looks Like When It Works
First-pass clean claim rate: 95%+ (industry average for mental health is 75–80%)
Days in AR: under 34
Endoscopy bundling error rate: zero — pre-submission audit on every multi-procedure case
Colonoscopy screening conversion accuracy: 100% — correct code and diagnosis on every polyp removal case
Infusion two-component capture rate: 100% — administration and drug supply billed on every infusion encounter
Prior auth denial rate: under 2%
Monthly report: revenue per physician, per procedure category (endoscopy vs infusion vs E&M vs other), per payer
Numbers based on industry benchmarks — your practice-specific results reported monthly.
FAQ
Gastroenterology Billing Questions
What is the most common billing error in gastroenterology?
Endoscopy bundling errors — either unbundling procedures that should be bundled (creating audit exposure) or over-bundling procedures that are separately billable (losing revenue). The free audit includes an endoscopy bundling review on a sample of recent multi-procedure cases.
How should colonoscopy be billed when a polyp is found and removed during a screening?
The CPT code changes from G0121/45378 to 45385 (with snare polypectomy) or 45380 (with biopsy). For Medicare patients, the screening diagnosis code is maintained alongside the polyp finding — preserving screening cost-sharing rules. For commercial payers, the rules vary by plan. Getting this right protects both the claim and the patient’s cost-sharing expectation.
We do biologic infusions in our office. Are we billing both components?
The most common infusion billing error in GI is missing J-code drug supply billing — submitting only the administration codes without billing the drug itself. On a biologic infusion worth thousands per dose, missing the drug supply code is a significant revenue loss per encounter. The audit will show your current infusion capture rate.
Does capsule endoscopy require prior authorization?
Yes — virtually every commercial payer requires prior authorization for capsule endoscopy, with documentation that prior endoscopy was non-diagnostic or that the procedure is contraindicated. We obtain auth before the procedure is scheduled and prepare the clinical documentation package that specific payers require.
We keep getting colonoscopy denials. What is usually causing them?
The most common colonoscopy denial causes are screening vs diagnostic coding mismatch, wrong diagnosis code for the coverage category, polyp removal conversion errors, and incomplete colonoscopy billed at full value. The free audit categorizes your recent colonoscopy denials by root cause.
What makes GI billing harder than general surgical billing?
Endoscopy bundling rules that differ from standard multiple procedure reduction, colonoscopy screening vs diagnostic distinction with polyp removal conversion complexity, biologic infusion two-component billing, capsule endoscopy prior auth requirements, and ERCP complexity. A general biller applies standard surgical billing logic to GI — and that approach creates both compliance risk and revenue loss on every procedure day.
Find Out What Your GI Practice Should Be Collecting Per Procedure Day
The free gastroenterology billing audit reviews your endoscopy bundling accuracy, colonoscopy screening vs diagnostic coding, infusion billing capture, prior auth process, and denial patterns — and shows you in plain numbers what every procedure day should be generating versus what it actually is.
📞 +1 (307) 443-6706
✉️ info@netixmedicalbilling.com